Matrix metalloproteinases cleave membrane-bound PD-L1 on CD90+ (myo-)fibroblasts in Crohn's disease and regulate Th1/Th17 cell responses.


Journal

International immunology
ISSN: 1460-2377
Titre abrégé: Int Immunol
Pays: England
ID NLM: 8916182

Informations de publication

Date de publication:
09 01 2020
Historique:
received: 28 11 2018
accepted: 30 09 2019
pubmed: 22 10 2019
medline: 3 6 2020
entrez: 22 10 2019
Statut: ppublish

Résumé

Increased T helper (Th)1/Th17 immune responses are a hallmark of Crohn's disease (CD) immunopathogenesis. CD90+ (myo-)fibroblasts (MFs) are abundant cells in the normal (N) intestinal mucosa contributing to mucosal tolerance via suppression of Th1 cell activity through cell surface membrane-bound PD-L1 (mPD-L1). CD-MFs have a decreased level of mPD-L1. Consequently, mPD-L1-mediated suppression of Th1 cells by CD-MFs is decreased, yet the mechanism responsible for the reduction in mPDL-1 is unknown. Increased expression of matrix metalloproteinases (MMPs) has been reported in CD. Herein we observed that when compared to N- and ulcerative colitis (UC)-MFs, CD-MFs increase in LPS-inducible levels of MMP-7 and -9 with a significant increase in both basal and inducible MMP-10. A similar pattern of MMP expression was observed in the CD-inflamed mucosa. Treatment of N-MFs with a combination of recombinant human MMP-7, -9 and -10 significantly decreased mPD-L1. In contrast, inhibition of MMP activity with MMP inhibitors or anti-MMP-10 neutralizing antibodies restores mPD-L1 on CD-MFs. CD-MFs demonstrated reduced capacity to suppress Th1 and Th17 responses from activated CD4+ T cells. By contrast, supplementation of the CD-MF:T-cell co-cultures with MMP inhibitors or anti-MMP neutralizing antibodies restored the CD-MF-mediated suppression. Our data suggest that (i) increased MMP-10 expression by CD-MFs and concomitant cleavage of PD-L1 from the surface of CD-MFs are likely to be one of the factors contributing to the decrease of mPD-L1-mediated suppression of Th1/Th17 cells in CD; and (ii) MMPs are likely to have a significant role in the intestinal mucosal immune responses.

Identifiants

pubmed: 31633754
pii: 5601595
doi: 10.1093/intimm/dxz060
pmc: PMC7185192
doi:

Substances chimiques

B7-H1 Antigen 0
CD274 protein, human 0
Thy-1 Antigens 0
Matrix Metalloproteinases EC 3.4.24.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

57-68

Subventions

Organisme : NCI NIH HHS
ID : R01 CA207051
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK103150
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR001440
Pays : United States

Informations de copyright

© The Japanese Society for Immunology. 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Front Immunol. 2013 Sep 30;4:307
pubmed: 24137162
Oncogene. 2003 Nov 27;22(54):8662-70
pubmed: 14647460
Immunity. 2018 Mar 20;48(3):434-452
pubmed: 29562194
Oncoimmunology. 2015 Oct 29;5(3):e1091146
pubmed: 27141350
Histopathology. 2001 Jul;39(1):50-9
pubmed: 11454044
Oncotarget. 2017 May 31;8(57):97671-97682
pubmed: 29228642
Sci Rep. 2016 May 26;6:26747
pubmed: 27226337
Infect Immun. 2000 Dec;68(12):7010-7
pubmed: 11083826
Int J Oncol. 2018 Feb;52(2):379-388
pubmed: 29345283
Mol Cell Biochem. 2003 Nov;253(1-2):269-85
pubmed: 14619979
Front Immunol. 2019 Jun 14;10:1337
pubmed: 31258527
Cell Immunol. 2014 Jul;290(1):72-9
pubmed: 24908630
Inflamm Bowel Dis. 2012 Jan;18(1):120-30
pubmed: 21438097
Front Immunol. 2018 May 30;9:1125
pubmed: 29910803
Immunobiology. 2016 Sep;221(9):927-33
pubmed: 27290609
J Crohns Colitis. 2014 Oct;8(10):1147-65
pubmed: 24731838
J Immunol. 1996 Aug 1;157(3):1261-70
pubmed: 8757634
J Immunol. 2013 Oct 1;191(7):3838-46
pubmed: 23997227
Eur J Clin Invest. 2017 Feb;47(2):109-116
pubmed: 27714784
Eur J Biochem. 1998 Apr 1;253(1):67-75
pubmed: 9578462
Am J Respir Cell Mol Biol. 2003 Sep;29(3 Pt 1):283-94
pubmed: 12663332
BMC Cancer. 2014 May 03;14:310
pubmed: 24885595
J Immunol. 2016 Aug 1;197(3):899-909
pubmed: 27316687
J Ovarian Res. 2017 May 5;10(1):33
pubmed: 28476165
J Immunol. 2014 Sep 1;193(5):2218-29
pubmed: 25070848
J Immunol. 2006 Nov 1;177(9):5968-79
pubmed: 17056521
Inflamm Bowel Dis. 2007 Feb;13(2):200-10
pubmed: 17206679
J Clin Gastroenterol. 2018 Aug;52(7):e53-e62
pubmed: 28723856
Inflamm Bowel Dis. 2005 Jun;11(6):567-75
pubmed: 15905704
Gastroenterology. 2005 Aug;129(2):550-64
pubmed: 16083712
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1964-1973
pubmed: 28442379
J Exp Med. 2017 Sep 4;214(9):2523-2533
pubmed: 28710273
Mediators Inflamm. 2015;2015:964131
pubmed: 25948887
Oncogene. 2018 Aug;37(34):4639-4661
pubmed: 29765155
Am J Physiol. 1997 Dec;273(6):G1341-8
pubmed: 9435560
Cancer Immunol Res. 2018 Dec;6(12):1459-1471
pubmed: 30209062
Scand J Gastroenterol. 2010 Aug;45(7-8):862-71
pubmed: 20367198
Cytokine. 2018 Sep;109:29-51
pubmed: 29903573
Gastroenterology. 2015 Nov;149(6):1564-1574.e3
pubmed: 26170138
Gastroenterology. 2008 Oct;135(4):1228-1237, 1237.e1-2
pubmed: 18760278
Gastroenterology. 2011 Jun;140(7):2019-30
pubmed: 21376048
Gastroenterol Res Pract. 2016;2016:2456179
pubmed: 27034654
Gut. 2006 Dec;55(12):1774-80
pubmed: 16682426
Dig Liver Dis. 2005 Aug;37(8):584-92
pubmed: 15869913
J Neurochem. 2016 Oct;139 Suppl 2:91-114
pubmed: 26525923
Prog Mol Biol Transl Sci. 2017;147:167-195
pubmed: 28413028
Clin Exp Immunol. 1997 Aug;109(2):377-86
pubmed: 9276536
Gastroenterology. 2011 May;140(6):1756-1767
pubmed: 21530742
Dig Dis. 2012;30(3):289-95
pubmed: 22722554
Arthritis Rheum. 2008 Apr;58(4):1001-9
pubmed: 18383392
Inflamm Bowel Dis. 2018 Jan 18;24(2):332-345
pubmed: 29361086

Auteurs

Jose E Aguirre (JE)

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA.
Institute of Translational Science, University of Texas Medical Branch, Galveston, TX, USA.

Ellen J Beswick (EJ)

Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.

Carl Grim (C)

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA.

Gabriela Uribe (G)

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA.
Department of Medicine at PennState Health Milton S. Hershey Medical Center, Hershey, PA, USA.

Marissa Tafoya (M)

Department of Pathology, University of New Mexico, Albuquerque, NM, USA.

Gabriela Chacon Palma (G)

School of Medicine, University of New Mexico, Albuquerque, NM, USA.

Von Samedi (V)

School of Medicine, University of New Mexico, Albuquerque, NM, USA.

Rohini McKee (R)

Department of Surgery at the University of New Mexico, Albuquerque, NM, USA.

Romain Villeger (R)

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA.

Yuriy Fofanov (Y)

Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA.

Yingzi Cong (Y)

Microbiology and Immunology at the University of Texas Medical Branch, Galveston, TX, USA.

Gregory Yochum (G)

Department of Biochemistry and Molecular Biology, PennState Health Milton S. Hershey Medical Center, Hershey, PA, USA.

Walter Koltun (W)

Department of Colorectal Surgery at PennState Health Milton S. Hershey Medical Center, Hershey, PA, USA.

Don Powell (D)

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA.
Institute of Translational Science, University of Texas Medical Branch, Galveston, TX, USA.

Irina V Pinchuk (IV)

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA.
Institute of Translational Science, University of Texas Medical Branch, Galveston, TX, USA.
Department of Medicine at PennState Health Milton S. Hershey Medical Center, Hershey, PA, USA.
Microbiology and Immunology at the University of Texas Medical Branch, Galveston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH